Stay updated on BI456906 Safety & Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.

Latest updates to the BI456906 Safety & Efficacy in NASH Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.0 is now shown, replacing Revision: v3.4.3.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded related topics: 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics'.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check23 days agoChange Detected- Removed references to Non-alcoholic fatty liver disease and related topics: MedlinePlus Genetics from the page. This affects only related topics/keywords and does not alter the core study content.SummaryDifference0.1%

- Check30 days agoChange Detected- Added related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics to the Related Topics section. This provides contextual background and quick access to related resources for the study.SummaryDifference0.1%

- Check38 days agoChange DetectedNew revision tag 'Revision: v3.4.2' appears, replacing the previous 'Revision: v3.4.1'; this indicates a minor metadata update to the page. No changes to study content, eligibility criteria, locations, or results are evident from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to BI456906 Safety & Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.